Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 284,208 | 250,456 | 209,154 | 221,172 | 165,317 |
| Marketable Securities | 96,212 | 143,197 | 129,192 | 156,706 | 197,166 |
| Receivables | 1,247 | N/A | N/A | N/A | 5,000 |
| TOTAL | $387,131 | $396,561 | $345,814 | $384,516 | $371,055 |
| Non-Current Assets | |||||
| PPE Net | 1,754 | 1,783 | 1,585 | 1,495 | 1,610 |
| Investments And Advances | 7,056 | 17,546 | 36,177 | 14,321 | 50,215 |
| Other Non-Current Assets | 477 | 662 | 1,174 | 1,414 | 1,353 |
| TOTAL | $9,287 | $19,991 | $38,936 | $17,230 | $53,178 |
| Total Assets | $396,418 | $416,552 | $384,750 | $401,746 | $424,233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,452 | 4,217 | 5,484 | 6,289 | 8,571 |
| Accrued Expenses | 11,826 | 15,262 | 18,139 | 12,916 | 13,781 |
| Other current liabilities | 197 | 342 | 851 | 925 | 898 |
| TOTAL | $14,475 | $19,821 | $24,474 | $20,130 | $23,250 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 33 | 180 | 419 |
| TOTAL | $N/A | $N/A | $33 | $180 | $419 |
| Total Liabilities | $14,475 | $19,821 | $24,507 | $20,310 | $23,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,369 | 27,366 | 27,348 | 27,304 | 27,277 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | -282,120 | -263,957 | -297,603 | -273,836 | -252,288 |
| Other shareholders' equity | -111 | -4 | 259 | 753 | 1,145 |
| TOTAL | $381,943 | $396,731 | $360,243 | $381,436 | $400,564 |
| Total Liabilities And Equity | $396,418 | $416,552 | $384,750 | $401,746 | $424,233 |